Summit Biosciences Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Summit Biosciences's estimated annual revenue is currently $23.5M per year.(i)
  • Summit Biosciences's estimated revenue per employee is $201,000

Employee Data

  • Summit Biosciences has 117 Employees.(i)
  • Summit Biosciences grew their employee count by 0% last year.

Summit Biosciences's People

NameTitleEmail/Phone
1
Chief Accounting OfficerReveal Email/Phone
2
Director Pharmaceutical DevelopmentReveal Email/Phone
3
Director OperationsReveal Email/Phone
4
Chief Business OfficerReveal Email/Phone
5
President and Chief Operating OfficerReveal Email/Phone
6
Associate Director Human ResourcesReveal Email/Phone
7
Director, Supply Chain ManagementReveal Email/Phone
8
Senior Manager, Analytical SciencesReveal Email/Phone
9
QC Chemistry ManagerReveal Email/Phone
10
Project ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$8.4M420%N/AN/A
#2
$970.9M30195%$47.1MN/A
#3
$1.4M70%N/AN/A
#4
$21.9M109-5%N/AN/A
#5
$12.9M6425%N/AN/A
#6
$14.7M879%N/AN/A
#7
$15.1M756%N/AN/A
#8
$109.9M54723%N/AN/A
#9
$12.3M615%N/AN/A
#10
$76.2M3790%N/AN/A
Add Company

What Is Summit Biosciences?

Our vision is to be recognized as the leader in the field of intranasal pharmaceutical drug products development and manufacturing. We intend to accomplish this by applying our unique formulation and manufacturing expertise and by leveraging our state-of-the-art cGMP manufacturing facility and our high-speed nasal products manufacturing and packaging equipment to address a high-growth, niche market.

keywords:N/A

N/A

Total Funding

117

Number of Employees

$23.5M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Summit Biosciences News

2022-04-19 - Global Leaders to Present Breakthroughs in Liquid Biopsy ...

The historic S.E.E. Summit (Safer, Easier, Earlier) is a free, virtual event ... Natera, Pillar Biosciences and StageZero Life Sciences.

2022-04-06 - Enochian BioSciences Inventor and Co-Founder Presents Data on Novel Clinical Approaches as the Invited, Concluding Plenary Speaker at the Innate Killer Summit

Serhat Gumrukçu, the inventor and co-founder of the Company, delivered the concluding Plenary Lecture at the Innate Killer Summit in San Diego,...

2022-03-30 - SHORELINE BIOSCIENCES ANNOUNCES ORAL ...

SHORELINE BIOSCIENCES ANNOUNCES ORAL PRESENTATION on ipsc-derived NK cell (iNK) platform AT INNATE KILLER SUMMIT meeting 2022.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$39.7M121-10%N/A
#2
$22.5M12521%N/A
#3
$30.9M1262%N/A
#4
$25.7M12860%N/A
#5
$20M129-16%N/A